IP Library › Granted Patent US 7,473,696
Granted Patent B2
US 7,473,696 · App. 10/577,584 · Granted Jan 6, 2009

CCR-2 antagonist salt

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,473,696
App. No.
10/577,584
Granted
Jan 6, 2009
Kind
B2
Abstract

An efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl} cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine and its succinate salt are provided. The succinate salt is crystalline and has superior properties.

Claims (3)

1. The compound:

isolated as a crystalline solid.

2. A pharmaceutical composition which comprises an inert carrier and the compound of claim 1 .

Assignments (4)
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023870/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2007
From: JENSEN, MARK; SIDLER, DANIEL RICHARD; LARSEN, ROBERT
To: MERCK & CO., INC.
Reel/Frame 019813/0082 →